
The Motley Fool recommends British American Tobacco P.l.c. and also recommends the following options: long January 2026 $40 calls on British American Tobacco and short January 2026 $40 puts on British American Tobacco. However, it's important to note that the Motley Fool's stance on investing in British American Tobacco may not necessarily mean it's the best stock to buy right now, as their recommendations can change over time.

Investing in British American Tobacco (BTI) comes with potential risks due to the declining trend in cigarette smoking. The main risks can be summarized as follows:
Declining cigarette volumes: As cigarette smoking declines, British American Tobacco's core business is negatively impacted. The company has experienced a significant volume decline in combustible products in recent years, which could worsen in the future. Although the company has managed to offset this revenue hit by raising prices, there's a limit to how much this strategy can be sustained.
Increased competition in the non-combustible market: As tobacco companies diversify into non-combustible products such as vapor pods, heating sticks, and oral pouches, competition in this market segment is intensifying. Although British American Tobacco is shifting its focus to these new categories, it is trailing behind its rival Philip Morris International, which has a more advanced smoke-free product portfolio.
Potential regulatory risks: The tobacco industry is heavily regulated, and further restrictions on cigarette sales and marketing could negatively impact British American Tobacco's business. Additionally, the company's non-combustible products may also face regulatory challenges, which could hinder their growth prospects6.
High dividend yield risk: While British American Tobacco's dividend yield of around 10% may be attractive to income-oriented investors, the high yield could also be a sign of increased risk3. If the company's financial performance deteriorates, it may be forced to cut its dividend, which would negatively impact investors relying on that income stream.
Leverage and financial risk: British American Tobacco has a higher debt-to-EBITDA ratio compared to some of its peers, which could make it more vulnerable to financial stress in times of adversity. Investors should closely monitor the company's balance sheet and debt situation.
In summary, while British American Tobacco is taking steps to diversify its operations and adapt to the decline in cigarette smoking, investors should be aware of these potential risks and closely monitor the company's performance and industry developments.

British American Tobacco (BTI) has a long history of consistent dividend payments, currently distributing dividends on a quarterly basis. The company's dividend yield is approximately 8.64%, outperforming 87.88% of global competitors in the Tobacco Products industry. Over the past three years, the company's annual dividend growth rate was 2.40%, decreasing to 0.90% per year when extended to a five-year horizon. Over the past decade, the annual dividends per share growth rate is 5.90%.
The sustainability of the dividend can be assessed by evaluating the company's payout ratio. As of 2023-06-30, British American Tobacco's dividend payout ratio is 0.44, suggesting that the company retains a significant part of its earnings, ensuring the availability of funds for future growth and unexpected downturns. The company's profitability rank is 8 out of 10 as of 2023-06-30, indicating good profitability prospects.
British American Tobacco's growth metrics also suggest a robust financial health. The company's growth rank of 8 out of 10 suggests a good growth trajectory relative to its competitors. Revenue per share and 3-year revenue growth rate of 2.60% per year indicates a strong revenue model, although it underperforms approximately 73.81% of global competitors. The company's 3-year EPS growth rate of 5.40% per year showcases its ability to grow earnings, a critical component for sustaining dividends in the long run. However, this rate underperforms approximately 60% of global competitors. Moreover, the company's 5-year EBITDA growth rate of -22.00% underperforms approximately 96.77% of global competitors.
In conclusion, British American Tobacco's consistent dividend payments, notable dividend growth rate, and reasonable payout ratio demonstrate its commitment to rewarding shareholders. Its profitability and growth metrics also suggest a robust financial health. However, investors should keep a close eye on the company's growth rates, which currently underperform a significant percentage of global competitors.